circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis
Redox Biology · 2024
DOI: 10.1016/j.redox.2024.103175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2024. Verfasst von Lianhong Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, Dalian Medical University, Western 9 Lvshunnan Road, Dalian, 116044, China. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Reperfusion Injury, RNA, Circular. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Exploring and discovering novel circRNAs is one of the ways to develop innovative drugs for the diagnosis and treatment of myocardial ischemia-reperfusion injury (MI/RI). In the work, some dysregulated circRNAs were found by microarray screening analysis in AC16 cells, and hsa_circRNA_104852 named circMIRIAF was screened, which was up-regulated in AC16 cells damaged by hypoxia-reoxygenation injury (H/RI). The comprehensive analysis of ceRNA network revealed the potential relationship of circMIRIAF/miR-544/WDR12. Then, the results of interaction research confirmed that circMIRIAF acted as sponge of miR-544 to positively regulate WDR12 protein expression. Further, the validation results indicate that miR-544 silencing increased the expression of WDR12, and WDR12 activated Notch1 signal to aggravate H/RI of AC16 cells and MI/RI of mice via regulating oxidative stress and inflammation. Furthermore, silencing circMIRIAF caused the decreased circMIRIAF levels and the increased miR-544 levels in cardiomyocytes, while excessive miR-544 inhibited WDR12 expression to alleviate the disorder. On the contrary, excessive circMIRIAF increased WDR12 expression by adsorbing miR-544 to exacerbate H/RI in AC16 cells. In addition, circMIRIAF siRNA reversed the aggravation of H/RI in cells caused by WDR12 overexpression. Overall, circMIRIAF can serve as a drug target or treating MI/RI, and circMIRIAF could sponge miR-544 and enhance WDR12 expression to aggravate MI/RI, which may provide a novel therapeutic strategy for MI/RI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, Dalian Medical University, Western 9 Lvshunnan Road, Dalian, 116044, China.
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
- Department of Pharmaceutical Analysis, Dalian Medical University, Western 9 Lvshunnan Road, Dalian, 116044, China. Electronic address: xulina627@163.com.
- Department of Pharmaceutical Analysis, Dalian Medical University, Western 9 Lvshunnan Road, Dalian, 116044, China; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China; Hubei Shizhen Laborator…
Zitieren
APA
Yin, L., Li, L., Gao, M., Qi, Y., Xu, L., & Peng, J. (2024). circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis. Redox Biology. https://doi.org/10.1016/j.redox.2024.103175
Vancouver
Yin L, Li L, Gao M, Qi Y, Xu L, Peng J. circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis. Redox Biology. 2024. doi:10.1016/j.redox.2024.103175
BibTeX
@article{Yin2024,
author = {Yin, Lianhong and Li, Lili and Gao, Meng and Qi, Yan and Xu, Lina and Peng, Jinyong},
title = {circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis},
journal = {Redox Biology},
year = {2024},
doi = {10.1016/j.redox.2024.103175}
}
EUVIMED